Athira Pharma
ATHA
ATHA
70 hedge funds and large institutions have $734M invested in Athira Pharma in 2020 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
30% more funds holding
Funds holding: 54 → 70 (+16)
0.4% less ownership
Funds ownership: 7.03% → 6.63% (-0.4%)
Holders
70
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$27.3M | |
| 2 | +$18.7M | |
| 3 | +$7.53M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.74M |
| 5 |
VA
VR Adviser
New York
|
+$5.82M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$8.31M | |
| 3 | -$8.28M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.86M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$6.45M |